Concepedia
Statistics
Publications
6
Citations
216
H-Index
Active since
2002
Affiliations
Orange County Research Center(Current)
University at Buffalo, State University of New York
T SILFANI is an author at Orange County Research Center specializing in medicine, cell signaling, and signal transduction.
Top concepts
MedicinePhysiologyAngiogenesisCell BiologyHypertensionInflammationHealth PolicyAnesthesiologyCell SignalingCell Physiology
Publications per year
2002–2007
Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension
Thomas D. Giles, Suzanne Oparil, T SILFANI et al. · Journal of Clinical Hypertension · 2007 · 81 citations · Full text
Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study
Joseph L. Izzo, Joel M. Neutel, T SILFANI et al. · Journal of Clinical Hypertension · 2007 · 43 citations · Full text
Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension
J NEUTEL, David H.G. Smith, T SILFANI et al. · Journal of Human Hypertension · 2006 · 32 citations
Hypertension, Health Policy, Pressure Measurement +7
Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells
T SILFANI, Ernest J. Freeman · Archives of Biochemistry and Biophysics · 2002 · 23 citations
Inflammation, Angiogenesis, Signal Transduction +12
Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate
Steven G. Chrysant, Thomas Marbury, T SILFANI · Blood Pressure Monitoring · 2006 · 22 citations
1–5 of 6